In recent years the field of nuclear medicine has been undergoing a renaissance. The widespread application of SPECT imaging and slow diffusion of PET techniques have revitalised nuclear imaging. At the same time rapid developments in radiopharmaceuticals have produced new imaging methods. These developments are discussed here.